Kaletra monotherapy controversy: AmfAR publishes overview.
The possibility of using Kaletra alone for selected patients instead of three or more antiretrovirals has led to controversy among HIV physicians, reviewed in a short article published by the American Foundation for AIDS Research.
D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000008:administration & dosage*
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir